Observational studyMedicine2025
Resuscitation and survival time in terminal cancer patients at the end of life: A retrospective observational study in a Chinese hospital.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
End-of-life care decisions for terminal cancer patients remain a clinical and ethical challenge, particularly regarding the use of aggressive interventions. This retrospective observational study aimed to evaluate the impact of different treatment schemes on survival time in terminal cancer patients. A total of 1266 patients were categorized into 4 groups: Group A received mechanical assistance and other rescue measures in the intensive care unit (ICU); Group B received drug rescue with cardiopulmonary resuscitation in the general ward; Group C received drug rescue only; and Group D received no rescue treatment. Overall survival was estimated using Kaplan-Meier analysis, and between-group differences were assessed with stratified log-rank tests. The median survival times were: Group A: 138.0 hours (95% confidence interval [CI]: 109.1-166.8), Group B: 54.5 hours (95% CI: 42.8-66.3), Group C: 60.0 hours (95% CI: 51.7-68.3), and Group D: 60.4 hours (95% CI: 53.9-66.8). Group A showed significantly longer survival than Groups B, C, and D (P < .05), whereas no significant difference was observed among Groups B, C, and D (P > .05). ICU-based resuscitation may provide modest survival benefit for terminal cancer patients, whereas drug-based rescue and cardiopulmonary resuscitation outside the ICU do not appear to extend survival. These findings support individualized, evidence-based decision-making for end-of-life interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.